RY
Ryman Healthcare Limited
RYHTY · OTC
$6.35 +3.93% (+$0.24)
Market Cap $2.17B
P/E Ratio -
Div. Yield -
ROE 10.42%
Bulios Fair Price
$3.97
37.5% downside
Current Price
$6.35
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RYHTY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
91 /100
Cheap P/B 0.51x
P/FCF 7.15x
P/S 3.03x
Growth
68 /100
Growing FCF growth 8.47%
Book val. growth 7.45%
Rev. growth 12.32%
Profitability
50 /100
Moderate Net margin 61.20%
Op. margin 16.57%
FCF margin 42.43%
Quality
1 /100
Poor ROE 10.42%
ROA 3.62%
Asset turnover 0.06x
Debt
42 /100
Moderate Current ratio 0.24x
Int. coverage -0.54x
Debt/Equity 0.40x
Stability
40 /100
Moderate Rev. volatility 3.36%
EPS volatility 5,115.56%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RYHTY
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Naomi James
Employees
7,800
Headquarters
Christchurch